Sun Pharmaceuticals Industries (BOM:524715) DeferredTaxAndRevenue: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524715 Sun Pharmaceuticals Industries Ltd BOM:524715
92 GF Score
Price ₹1,900.90
GF Value ₹1,954.87
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries DeferredTaxAndRevenue?

Sun Pharmaceuticals Industries BOM:524715 -0.01% 92 DeferredTaxAndRevenue is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:524715 with a GF Score™ of 92/100 and a GF Value™ of ₹1,954.87 (Fairly Valued). The stock has 2 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Sun Pharmaceuticals Industries's current deferred tax and revenue for the quarter that ended in Jun. 2026 was ₹0 Mil.

Sun Pharmaceuticals Industries DeferredTaxAndRevenue Related Terms

Sun Pharmaceuticals Industries DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Sun Pharmaceuticals Industries's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries DeferredTaxAndRevenue Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sun Pharmaceuticals Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:524715
92GF Score
Sun Pharmaceuticals Industries Ltd BOM:524715
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0 Mil mean?
Sun Pharmaceuticals Industries (BOM:524715) has a DeferredTaxAndRevenue of ₹0 Mil as of Jun. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Sun Pharmaceuticals Industries.
Is Sun Pharmaceuticals Industries' DeferredTaxAndRevenue too high?
Sun Pharmaceuticals Industries' current DeferredTaxAndRevenue is ₹0 Mil. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' DeferredTaxAndRevenue compare to ZTS and UTHR?
Sun Pharmaceuticals Industries' DeferredTaxAndRevenue of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Sun Pharmaceuticals Industries. Sun Pharmaceuticals Industries's current DeferredTaxAndRevenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (BOM:524715) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,954.87, compared to a current price of ₹1,900.90 — trading 2.8% below its estimated fair value. The current DeferredTaxAndRevenue is ₹0 Mil. Sun Pharmaceuticals Industries' overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (BOM:524715), the current DeferredTaxAndRevenue is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharmaceuticals Industries (BOM:524715) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be undervalued. The current stock price of ₹1,900.90 is trading 2.8% below its estimated GF Value™ of ₹1,954.87. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for BOM:524715:

  • DeferredTaxAndRevenue: ₹0 Mil
  • GF Value™: ₹1,954.87 vs. price of ₹1,900.90 (2.8% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the BOM:524715 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharmaceuticals Industries Business Description

Other Exchanges SUNPHARMA:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
92GF Score

Get the complete analysis for BOM:524715

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,900.90
Price
₹1,954.87
GF Value